Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen's California Lab Gains CLIA Certification

NEW YORK (GenomeWeb News) – Genetic testing company Perlegen Sciences has received certification for a new clinical lab in Mountain View, Calif., the company said today.

The company said it received Clinical Laboratory Improvement Amendments certification from the California Department of Public Health's Laboratory Field Services and has opened the facility.

Perlegen CEO Bryan Walser said in a statement that the opening of the lab is "a significant advance in our efforts to commercialize Perlegen's key genetic tests," which the company will begin with the launch this fall of the MammaPlus genetic test for breast cancer risk.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.